Triple-negative breast cancer, or TNBC, presents numerous treatment challenges. Compared with other forms of breast cancer, it’s more likely to have...

In breast cancer patients, adding the immunotherapy drug nivolumab to pre-surgery chemotherapy can significantly enhance patient outcomes, as...

Australian researchers achieve a breakthrough in improving breast cancer cure rates, offering new hope for patients worldwide.

Datopotamab deruxtecan (Dato─DXd) has been recommended for approval in the European Union (EU) for the treatment of adult patients with unresectable...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...

Australian researchers have found a new treatment that can dramatically improve survival rates for a common form of breast cancer.

The results of a VHIO-led study published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR), underscore...

Datroway (datopotamab deruxtecan─dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone...

On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk, a Trop-2-directed antibody and topoisomerase inhibitor...

A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than...